Forecast: Production Value of Biotechnology Research and Experimental Development in France

The production value of biotechnology research and experimental development in France exhibited fluctuations over the past decade, with a significant increase in production value during certain years, such as 2016 and 2017. The year 2018 saw a sharp decrease, but a recovery trend emerged from 2019 onwards. As of 2023, the production value stood at €2.28 billion, showing a stable growth pattern in recent years. The average annual growth rate (CAGR) over the last five years was approximately 11.56%.

Year-on-year variations for the past two years indicated moderate growth, with 2022 recording a 4.08% increase and 2023 showing a slight decrease to 3.87%. Looking ahead, forecast data suggest a steady increase in production value, with a predicted CAGR of 2.63% from 2023 to 2028, amounting to a 13.84% growth rate over this five-year period.

Future trends to watch for include increased investment in biotechnology R&D, potential breakthroughs in medical and agricultural biotechnology, and supportive government policies that may enhance R&D activities. Monitoring global competition and advancements in genomic research could also play a critical role in shaping the future trajectory of this sector in France.